News

Carl Morck is psychologically damaged. He's socially insufferable. And he's a departmental embarrassment. Yet this broken man becomes an incredibly ...
Using advanced single-nuclei RNA sequencing (snRNA-seq) and a widely used preclinical model for Alzheimer's disease, ...
Spending time in nature boosts mental clarity, mood, and attention span—offering measurable benefits like better focus, less ...
Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance 1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and ...
Functional Neurological Disorder (FND) is an often misunderstood condition that causes life-altering neurological symptoms without structural brain damage. For those applying for PIP, understanding ...
But a company, Neuro Control, had already signed on to commercialize ... originally followed French’s story for a 2022 piece in Nature. He says French is one of the lucky ones — Case Western ...
Try these fun ways to engage the whole family next time you’re exploring your favorite national park or place in nature. NPCA and our partner Nature Valley know the importance of protecting parks to ...
By utilizing the power of nature, Neuro Surge aims to elevate the user’s mental acuity, enhance mood stability, and improve overall cognitive resilience. This supplement is ideal for individuals ...
Neuro Surge emerges as a groundbreaking solution, specifically designed to cater to the nutritional needs of the brain. With the modern diet often lacking essential nutrients, many individuals ...
In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report). The company’s shares closed yesterday at $17.00. According to ...
From disrupted sleep to heightened seizure risks, climate change is silently reshaping neurological health—discover how rising temperatures and pollution are putting vulnerable populations at ...
Lake Street analyst Frank Takkinen reiterated a Buy rating on ClearPoint Neuro (CLPT – Research Report) today. The company’s shares closed yesterday at $16.68. Pick the best stocks and ...